Utah Retirement Systems cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 59,039 shares of the medical research company’s stock after selling 400 shares during the period. Utah Retirement Systems’ holdings in Agilent Technologies were worth $3,501,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of A. Parallel Advisors LLC boosted its stake in Agilent Technologies by 5.3% in the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after buying an additional 131 shares in the last quarter. Trust Co. of Vermont boosted its stake in Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares in the last quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC boosted its stake in Agilent Technologies by 17.2% in the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock valued at $196,000 after buying an additional 486 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in Agilent Technologies during the second quarter valued at about $200,000. Finally, ELM Advisors LLC purchased a new stake in Agilent Technologies during the second quarter valued at about $202,000.

Agilent Technologies, Inc. (NYSE:A) opened at 63.49 on Wednesday. The company has a 50-day moving average of $60.73 and a 200 day moving average of $56.62. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $63.63. The stock has a market cap of $20.44 billion, a price-to-earnings ratio of 32.74 and a beta of 1.30.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $0.49 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post $2.32 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This story was published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/utah-retirement-systems-cuts-position-in-agilent-technologies-inc-a/1531333.html.

Several research firms have issued reports on A. Bank of America Corporation raised their price target on shares of Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 16th. Barclays PLC reaffirmed a “buy” rating and set a $67.00 price target on shares of Agilent Technologies in a research note on Wednesday, July 19th. Wells Fargo & Company raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $42.92 to $60.73 in a research note on Wednesday, July 12th. Deutsche Bank AG reaffirmed a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a research note on Thursday, June 22nd. Finally, BidaskClub raised shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Sunday, August 6th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $63.18.

In related news, CFO Didier Hirsch sold 5,710 shares of Agilent Technologies stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $60.60, for a total transaction of $346,026.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of Agilent Technologies stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $61.26, for a total value of $306,300.00. Following the sale, the insider now directly owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The disclosure for this sale can be found here. Over the last three months, insiders have sold 122,308 shares of company stock valued at $7,578,624.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.